Go Pro
Wedbush

Wedbush Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at Wedbush. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Wedbush's equity research team. MarketBeat is not affiliated with or endorsed by Wedbush.

Average Return
00.00% 12-Month ROI
Total Ratings
966 Last 12 Months
Buy Ratings
746 Last 12 Months
Sell Ratings
19 Last 12 Months
Companies Covered
272 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
Micron Technology, Inc. stock logo
MU
Micron Technology
$1,053.98
-2.6%
9/28/2026Reiterated Rating$1,400.00OutperformView details for Wedbush rating of Micron Technology (NASDAQ:MU) on 9/28/2026
Zscaler, Inc. stock logo
ZS
Zscaler
$199.39
+3.3%
9/28/2026Reiterated Rating$215.00OutperformView details for Wedbush rating of Zscaler (NASDAQ:ZS) on 9/28/2026
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
$84.19
-0.3%
9/24/2026Set Price Target$120.00View details for Wedbush rating of Oruka Therapeutics (NASDAQ:ORKA) on 9/24/2026
Eupraxia Pharmaceuticals Inc. stock logo
EPRX
Eupraxia Pharmaceuticals
$8.21
+2.5%
9/24/2026Initiated Coverage$17.00OutperformView details for Wedbush rating of Eupraxia Pharmaceuticals (NASDAQ:EPRX) on 9/24/2026
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
$84.19
-0.3%
9/24/2026Reiterated Rating$165.00OutperformView details for Wedbush rating of Oruka Therapeutics (NASDAQ:ORKA) on 9/24/2026
Everpure, Inc. stock logo
P
Everpure
$129.41
+2.7%
9/24/2026Reiterated Rating$130.00OutperformView details for Wedbush rating of Everpure (NYSE:P) on 9/24/2026
Roku, Inc. stock logo
ROKU
Roku
$152.67
0.0%
9/24/2026Reiterated Rating$155.00NeutralView details for Wedbush rating of Roku (NASDAQ:ROKU) on 9/24/2026
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
$1.11
-1.8%
9/23/2026Set Price Target$4.00View details for Wedbush rating of Compass Therapeutics (NASDAQ:CMPX) on 9/23/2026
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
$26.85
+3.1%
9/23/2026Reiterated Rating$48.00OutperformView details for Wedbush rating of Maze Therapeutics (NASDAQ:MAZE) on 9/23/2026
Nektar Therapeutics stock logo
NKTR
Nektar Therapeutics
$60.40
+5.9%
9/23/2026Lower Price Target$80.00 ➝ $50.00NeutralView details for Wedbush rating of Nektar Therapeutics (NASDAQ:NKTR) on 9/23/2026
Shopify Inc. stock logo
SHOP
Shopify
$144.01
+1.2%
9/23/2026Reiterated Rating$176.00OutperformView details for Wedbush rating of Shopify (NASDAQ:SHOP) on 9/23/2026
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
$11.62
+1.5%
9/23/2026Reiterated Rating$22.00OutperformView details for Wedbush rating of Telix Pharmaceuticals (NASDAQ:TLX) on 9/23/2026
Willdan Group, Inc. stock logo
WLDN
Willdan Group
$77.21
-2.1%
9/23/2026Reiterated Rating$130.00OutperformView details for Wedbush rating of Willdan Group (NASDAQ:WLDN) on 9/23/2026
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
$1.11
-1.8%
9/22/2026Downgrade$5.00 ➝ $1.00Outperform ➝ NeutralView details for Wedbush rating of Compass Therapeutics (NASDAQ:CMPX) on 9/22/2026
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
$96.85
+6.4%
9/22/2026Lower Price Target$140.00 ➝ $118.00NeutralView details for Wedbush rating of Abivax (NASDAQ:ABVX) on 9/22/2026
IonQ, Inc. stock logo
IONQ
IonQ
$44.59
-2.0%
9/22/2026Reiterated Rating$75.00OutperformView details for Wedbush rating of IonQ (NYSE:IONQ) on 9/22/2026
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
$61.57
+3.6%
9/22/2026Reiterated Rating$76.00OutperformView details for Wedbush rating of Travere Therapeutics (NASDAQ:TVTX) on 9/22/2026
fuboTV Inc. stock logo
FUBO
fuboTV
$9.44
-2.1%
9/18/2026Reiterated Rating$19.00OutperformView details for Wedbush rating of fuboTV (NYSE:FUBO) on 9/18/2026
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
$36.72
-0.6%
9/18/2026Lower Price Target$71.00 ➝ $55.00OutperformView details for Wedbush rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 9/18/2026
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$31.86
-1.4%
9/16/2026Reiterated Rating$55.00OutperformView details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 9/16/2026
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
$5.63
-2.0%
9/16/2026Reiterated Rating$11.00OutperformView details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 9/16/2026
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$2.61
+0.4%
9/16/2026Reiterated Rating$15.00OutperformView details for Wedbush rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 9/16/2026
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
$49.13
+1.0%
9/15/2026Reiterated Rating$64.00OutperformView details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 9/15/2026
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
$10.02
+4.5%
9/15/2026Boost Price Target$16.00 ➝ $17.00OutperformView details for Wedbush rating of Benitec Biopharma (NASDAQ:BNTC) on 9/15/2026
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
$2.50
-0.8%
9/15/2026Reiterated Rating$11.00OutperformView details for Wedbush rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 9/15/2026
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
$5.12
-2.1%
9/15/2026Boost Price Target$5.00 ➝ $6.00NeutralView details for Wedbush rating of Sionna Therapeutics (NASDAQ:SION) on 9/15/2026
Crescent Biopharma, Inc. stock logo
CBIO
Crescent Biopharma
$14.53
+3.9%
9/14/2026Reiterated Rating$27.00OutperformView details for Wedbush rating of Crescent Biopharma (NASDAQ:CBIO) on 9/14/2026
Roblox Corporation stock logo
RBLX
Roblox
$41.88
-9.8%
9/14/2026Boost Price Target$40.00 ➝ $48.00NeutralView details for Wedbush rating of Roblox (NYSE:RBLX) on 9/14/2026
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
$49.13
+1.0%
9/14/2026Reiterated Rating$64.00OutperformView details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 9/14/2026
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
$11.62
+1.5%
9/14/2026Reiterated Rating$22.00OutperformView details for Wedbush rating of Telix Pharmaceuticals (NASDAQ:TLX) on 9/14/2026
Meta Platforms, Inc. stock logo
META
Meta Platforms
$715.62
-4.8%
9/11/2026Boost Price Target$595.00 ➝ $650.00NeutralView details for Wedbush rating of Meta Platforms (NASDAQ:META) on 9/11/2026
CrowdStrike stock logo
CRWD
CrowdStrike
$259.25
+2.8%
9/11/2026Reiterated Rating$250.00OutperformView details for Wedbush rating of CrowdStrike (NASDAQ:CRWD) on 9/11/2026
Datadog, Inc. stock logo
DDOG
Datadog
$268.70
+0.2%
9/11/2026Initiated Coverage$260.00 ➝ $275.00OutperformView details for Wedbush rating of Datadog (NASDAQ:DDOG) on 9/11/2026
Elastic N.V. stock logo
ESTC
Elastic
$88.21
+0.1%
9/11/2026Initiated Coverage$125.00OutperformView details for Wedbush rating of Elastic (NYSE:ESTC) on 9/11/2026
Palo Alto Networks, Inc. stock logo
PANW
Palo Alto Networks
$392.09
+4.6%
9/11/2026Initiated Coverage$400.00OutperformView details for Wedbush rating of Palo Alto Networks (NASDAQ:PANW) on 9/11/2026
Rubrik, Inc. stock logo
RBRK
Rubrik
$113.19
+3.3%
9/11/2026Initiated Coverage$90.00 ➝ $120.00OutperformView details for Wedbush rating of Rubrik (NYSE:RBRK) on 9/11/2026
SentinelOne, Inc. stock logo
S
SentinelOne
$22.78
+1.8%
9/11/2026Initiated Coverage$25.00OutperformView details for Wedbush rating of SentinelOne (NYSE:S) on 9/11/2026
Varonis Systems, Inc. stock logo
VRNS
Varonis Systems
$47.92
+3.6%
9/11/2026Reiterated Rating$46.00Outperform ➝ NeutralView details for Wedbush rating of Varonis Systems (NASDAQ:VRNS) on 9/11/2026
Zscaler, Inc. stock logo
ZS
Zscaler
$199.39
+3.3%
9/11/2026Initiated Coverage$215.00OutperformView details for Wedbush rating of Zscaler (NASDAQ:ZS) on 9/11/2026
Qualys, Inc. stock logo
QLYS
Qualys
$173.83
+0.8%
9/10/2026Downgrade$175.00Outperform ➝ NeutralView details for Wedbush rating of Qualys (NASDAQ:QLYS) on 9/10/2026
Management just bought 2.8 million shares (Ad)

Management just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 in one quarter. Institutions own about 83% of shares, including BlackRock's 32 million shares worth $716 million and Vanguard's 48 million shares worth nearly $1.1 billion. A new multi-year deal with Palantir adds an AI-driven edge to this energy producer's operations.tc pixel

Watch the briefing on this buyback and AI opportunity now
Telos Corporation stock logo
TLS
Telos
$4.06
+0.5%
9/10/2026Downgrade$5.00Outperform ➝ NeutralView details for Wedbush rating of Telos (NASDAQ:TLS) on 9/10/2026
Dynatrace, Inc. stock logo
DT
Dynatrace
$57.85
-0.2%
9/10/2026Downgrade$54.00Outperform ➝ NeutralView details for Wedbush rating of Dynatrace (NYSE:DT) on 9/10/2026
Check Point Software Technologies Ltd. stock logo
CHKP
Check Point Software Technologies
$129.27
-1.5%
9/10/2026Downgrade$135.00Outperform ➝ NeutralView details for Wedbush rating of Check Point Software Technologies (NASDAQ:CHKP) on 9/10/2026
Tenable Holdings, Inc. stock logo
TENB
Tenable
$34.47
+2.9%
9/10/2026Downgrade$29.00Outperform ➝ UnderperformView details for Wedbush rating of Tenable (NASDAQ:TENB) on 9/10/2026
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
$2.90
+1.4%
9/10/2026Boost Price Target$6.00 ➝ $8.00OutperformView details for Wedbush rating of Pyxis Oncology (NASDAQ:PYXS) on 9/10/2026
Datadog, Inc. stock logo
DDOG
Datadog
$268.70
+0.2%
9/10/2026UpgradeStrong-BuyView details for Wedbush rating of Datadog (NASDAQ:DDOG) on 9/10/2026
Dynatrace, Inc. stock logo
DT
Dynatrace
$57.85
-0.2%
9/10/2026UpgradeHoldView details for Wedbush rating of Dynatrace (NYSE:DT) on 9/10/2026
Immunic, Inc. stock logo
IMUX
Immunic
$9.51
+1.7%
9/10/2026Reiterated Rating$45.00OutperformView details for Wedbush rating of Immunic (NASDAQ:IMUX) on 9/10/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
$5.05
+6.1%
9/10/2026Boost Price Target$10.00 ➝ $13.00OutperformView details for Wedbush rating of Opus Genetics (NASDAQ:IRD) on 9/10/2026
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
$64.92
-0.5%
9/10/2026Reiterated Rating$100.00OutperformView details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 9/10/2026
Qualys, Inc. stock logo
QLYS
Qualys
$173.83
+0.8%
9/10/2026UpgradeHoldView details for Wedbush rating of Qualys (NASDAQ:QLYS) on 9/10/2026
Tenable Holdings, Inc. stock logo
TENB
Tenable
$34.47
+2.9%
9/10/2026UpgradeStrong SellView details for Wedbush rating of Tenable (NASDAQ:TENB) on 9/10/2026
Telos Corporation stock logo
TLS
Telos
$4.06
+0.5%
9/10/2026UpgradeHoldView details for Wedbush rating of Telos (NASDAQ:TLS) on 9/10/2026
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
$21.45
-1.4%
9/10/2026Reiterated Rating$53.00OutperformView details for Wedbush rating of Tyra Biosciences (NASDAQ:TYRA) on 9/10/2026
Varonis Systems, Inc. stock logo
VRNS
Varonis Systems
$47.92
+3.6%
9/10/2026UpgradeHoldView details for Wedbush rating of Varonis Systems (NASDAQ:VRNS) on 9/10/2026
Pharvaris N.V. stock logo
PHVS
Pharvaris
$31.91
-0.3%
9/9/2026Boost Price Target$42.00 ➝ $50.00OutperformView details for Wedbush rating of Pharvaris (NASDAQ:PHVS) on 9/9/2026
BridgeBio Oncology Therapeutics, Inc stock logo
BBOT
BridgeBio Oncology Therapeutics
$3.81
-3.5%
9/9/2026Reiterated Rating$25.00OutperformView details for Wedbush rating of BridgeBio Oncology Therapeutics (NASDAQ:BBOT) on 9/9/2026
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$24.23
-0.2%
9/9/2026Reiterated Rating$65.00OutperformView details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 9/9/2026
Monte Rosa Therapeutics, Inc. stock logo
GLUE
Monte Rosa Therapeutics
$11.71
-0.5%
9/9/2026Reiterated Rating$27.00OutperformView details for Wedbush rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 9/9/2026
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$11.42
-2.8%
9/9/2026Boost Price Target$12.00 ➝ $13.00NeutralView details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 9/9/2026
Spyre Therapeutics, Inc. stock logo
SYRE
Spyre Therapeutics
$85.79
+0.1%
9/9/2026Reiterated Rating$123.00OutperformView details for Wedbush rating of Spyre Therapeutics (NASDAQ:SYRE) on 9/9/2026
Pharvaris N.V. stock logo
PHVS
Pharvaris
$31.91
-0.3%
9/8/2026Reiterated Rating$42.00OutperformView details for Wedbush rating of Pharvaris (NASDAQ:PHVS) on 9/8/2026
Uber Technologies, Inc. stock logo
UBER
Uber Technologies
$68.12
-2.2%
9/8/2026Reiterated Rating$91.00OutperformView details for Wedbush rating of Uber Technologies (NYSE:UBER) on 9/8/2026
argenex SE stock logo
ARGX
argenex
$972.25
+1.3%
9/3/2026Reiterated Rating$1,150.00OutperformView details for Wedbush rating of argenex (NASDAQ:ARGX) on 9/3/2026
NetApp, Inc. stock logo
NTAP
NetApp
$204.41
+1.6%
9/3/2026Boost Price Target$150.00 ➝ $170.00NeutralView details for Wedbush rating of NetApp (NASDAQ:NTAP) on 9/3/2026
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
$14.41
-0.6%
9/3/2026Lower Price Target$30.00 ➝ $23.00NeutralView details for Wedbush rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 9/3/2026
TScan Therapeutics, Inc. stock logo
TCRX
TScan Therapeutics
$0.34
9/2/2026Downgrade$1.00Buy ➝ NeutralView details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 9/2/2026
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
$64.92
-0.5%
9/2/2026Boost Price Target$88.00 ➝ $100.00OutperformView details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 9/2/2026
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
$230.05
+2.0%
9/1/2026Reiterated Rating$327.00OutperformView details for Wedbush rating of Ascendis Pharma A/S (NASDAQ:ASND) on 9/1/2026
Meta Platforms, Inc. stock logo
META
Meta Platforms
$715.62
-4.8%
9/1/2026Reiterated Rating$595.00NeutralView details for Wedbush rating of Meta Platforms (NASDAQ:META) on 9/1/2026
VeriSign, Inc. stock logo
VRSN
VeriSign
$282.07
-1.8%
9/1/2026Boost Price Target$324.00 ➝ $341.00OutperformView details for Wedbush rating of VeriSign (NASDAQ:VRSN) on 9/1/2026
Crescent Biopharma, Inc. stock logo
CBIO
Crescent Biopharma
$14.53
+3.9%
8/27/2026Reiterated Rating$27.00OutperformView details for Wedbush rating of Crescent Biopharma (NASDAQ:CBIO) on 8/27/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
$228.86
+1.7%
8/27/2026Boost Price Target$330.00 ➝ $345.00OutperformView details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 8/27/2026
Everpure, Inc. stock logo
P
Everpure
$129.41
+2.7%
8/27/2026Boost Price Target$127.00 ➝ $130.00OutperformView details for Wedbush rating of Everpure (NYSE:P) on 8/27/2026
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
$201.74
-1.6%
8/27/2026Boost Price Target$201.00 ➝ $225.00OutperformView details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 8/27/2026
Spyre Therapeutics, Inc. stock logo
SYRE
Spyre Therapeutics
$85.79
+0.1%
8/26/2026Lower Price Target$130.00 ➝ $123.00OutperformView details for Wedbush rating of Spyre Therapeutics (NASDAQ:SYRE) on 8/26/2026
Best Buy Co., Inc. stock logo
BBY
Best Buy
$89.99
-0.6%
8/24/2026Reiterated RatingBuyView details for Wedbush rating of Best Buy (NYSE:BBY) on 8/24/2026
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
$49.13
+1.0%
8/21/2026Reiterated Rating$64.00OutperformView details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 8/21/2026
Everpure, Inc. stock logo
P
Everpure
$129.41
+2.7%
8/21/2026Boost Price Target$105.00 ➝ $127.00OutperformView details for Wedbush rating of Everpure (NYSE:P) on 8/21/2026
DoorDash, Inc. stock logo
DASH
DoorDash
$178.39
-7.7%
8/20/2026Boost Price Target$205.00 ➝ $220.00NeutralView details for Wedbush rating of DoorDash (NASDAQ:DASH) on 8/20/2026
Wix.com Ltd. stock logo
WIX
Wix.com
$69.60
-5.7%
8/20/2026Boost Price Target$55.00 ➝ $80.00NeutralView details for Wedbush rating of Wix.com (NASDAQ:WIX) on 8/20/2026
Duolingo, Inc. stock logo
DUOL
Duolingo
$134.30
-6.4%
8/20/2026Boost Price Target$139.00 ➝ $150.00NeutralView details for Wedbush rating of Duolingo (NASDAQ:DUOL) on 8/20/2026
Expedia Group, Inc. stock logo
EXPE
Expedia Group
$264.23
+0.0%
8/20/2026Boost Price Target$334.00 ➝ $417.00OutperformView details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 8/20/2026
eBay Inc. stock logo
EBAY
eBay
$107.32
-0.5%
8/20/2026Boost Price Target$135.00 ➝ $137.00OutperformView details for Wedbush rating of eBay (NASDAQ:EBAY) on 8/20/2026
Criteo S.A. stock logo
CRTO
Criteo
$15.80
-2.9%
8/20/2026Lower Price Target$30.00 ➝ $25.00OutperformView details for Wedbush rating of Criteo (NASDAQ:CRTO) on 8/20/2026
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
$11.62
+1.5%
8/20/2026Reiterated Rating$22.00OutperformView details for Wedbush rating of Telix Pharmaceuticals (NASDAQ:TLX) on 8/20/2026
Aktis Oncology stock logo
AKTS
Aktis Oncology
$19.35
-0.4%
8/19/2026Initiated Coverage$35.00OutperformView details for Wedbush rating of Aktis Oncology (NASDAQ:AKTS) on 8/19/2026
Climb Bio, Inc. stock logo
CLYM
Climb Bio
$11.74
+0.7%
8/19/2026Reiterated Rating$20.00OutperformView details for Wedbush rating of Climb Bio (NASDAQ:CLYM) on 8/19/2026
Ardelyx, Inc. stock logo
ARDX
Ardelyx
$3.41
-0.3%
8/18/2026Reiterated Rating$9.00OutperformView details for Wedbush rating of Ardelyx (NASDAQ:ARDX) on 8/18/2026
argenex SE stock logo
ARGX
argenex
$972.25
+1.3%
8/18/2026Boost Price Target$1,050.00 ➝ $1,150.00OutperformView details for Wedbush rating of argenex (NASDAQ:ARGX) on 8/18/2026
MILLIONAIRE MASTERCLASS INVITE: Altucher (Ad)

James Altucher says Elon Musk is preparing an unprecedented project set to surface on December 8th. Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans. Attendees who join early can also access a $1,000 bonus offer included with the presentation.tc pixel

Watch James Altucher's free masterclass before December 8th
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
$7.21
-2.7%
8/18/2026Reiterated Rating$38.00OutperformView details for Wedbush rating of Cartesian Therapeutics (NASDAQ:RNAC) on 8/18/2026
Willdan Group, Inc. stock logo
WLDN
Willdan Group
$77.21
-2.1%
8/18/2026Reiterated Rating$130.00OutperformView details for Wedbush rating of Willdan Group (NASDAQ:WLDN) on 8/18/2026
Immunic, Inc. stock logo
IMUX
Immunic
$9.51
+1.7%
8/17/2026Initiated Coverage$45.00OutperformView details for Wedbush rating of Immunic (NASDAQ:IMUX) on 8/17/2026
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
$32.50
-0.1%
8/17/2026Reiterated Rating$34.00NeutralView details for Wedbush rating of Vera Therapeutics (NASDAQ:VERA) on 8/17/2026
Globant S.A. stock logo
GLOB
Globant
$33.82
-2.0%
8/14/2026Downgrade$54.00 ➝ $37.00Outperform ➝ NeutralView details for Wedbush rating of Globant (NYSE:GLOB) on 8/14/2026
EIKN
Eikon Therapeutics
$7.91
-0.1%
8/14/2026Lower Price Target$5.00 ➝ $4.00UnderperformView details for Wedbush rating of Eikon Therapeutics (NASDAQ:EIKN) on 8/14/2026
Fate Therapeutics, Inc. stock logo
FATE
Fate Therapeutics
$2.38
+1.3%
8/14/2026Reiterated Rating$7.00OutperformView details for Wedbush rating of Fate Therapeutics (NASDAQ:FATE) on 8/14/2026
Sandisk Corporation stock logo
SNDK
Sandisk
$1,712.89
-3.7%
8/14/2026Reiterated Rating$2,000.00OutperformView details for Wedbush rating of Sandisk (NASDAQ:SNDK) on 8/14/2026
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
$27.55
+2.2%
8/14/2026Reiterated Rating$45.00OutperformView details for Wedbush rating of Zenas BioPharma (NASDAQ:ZBIO) on 8/14/2026
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
$26.67
+0.7%
8/13/2026Boost Price Target$24.00 ➝ $26.00NeutralView details for Wedbush rating of Alto Neuroscience (NYSE:ANRO) on 8/13/2026

MarketBeat's community ratings are surveys of what our community members think about Wedbush and other research firms in the last 90 days. Vote "Outperform" if you believe Wedbush's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Wedbush's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
0.0out of 5 (last 90 days)
0 of 5 stars
OUTPERFORM VOTES
0 Believe will outperform the market
UNDERPERFORM VOTES
0 Believe will underperform the market

Wedbush's equity research team has issued ratings on 271 companies across 9 sectors over the past 12 months, covered by 19 analysts. The Wedbush analysts below are listed by number of ratings issued in the last year.

Wedbush Stock Coverage by Sector

Wedbush concentrates its research most heavily in Healthcare (44.1%), Technology (24.6%) and Consumer Discretionary (10.7%). The chart below shows how Wedbush's 272 rated companies are distributed across all 9 sectors it covers.

Wedbush - Frequently Asked Questions

Wedbush's analysts currently have buy-equivalent ratings on 226 companies. Recent upgrades to buy include Eupraxia Pharmaceuticals, Datadog, Replimune Group, Airbnb and SK hynix.

Wedbush's highest-rated analysts by MarketBeat's accuracy score include Laura Chico, Robert Driscoll and David Nierengarten. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 20 analysts at Wedbush.

Wedbush has the deepest coverage in Healthcare (44.1% of rated companies), Technology (24.6% of rated companies), Consumer Discretionary (10.7% of rated companies), Communication Services (8.8% of rated companies) and Industrials (5.1% of rated companies).

Wedbush issued 966 ratings over the last 12 months across 272 companies — an average of roughly 80 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current Wedbush analyst actions.

A buy rating indicates the analyst expects the stock to outperform the market over the next 12 months. A hold suggests the stock will perform in line with the market. A sell rating indicates expected underperformance. Wedbush uses Outperform, Neutral, and Underperform as their equivalents.